A detailed history of Bank Of America Corp transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Bank Of America Corp holds 851,321 shares of RDY stock, worth $67.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
851,321
Previous 891,650 4.52%
Holding current value
$67.8 Million
Previous $65.4 Million 0.83%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$68.26 - $76.19 $2.75 Million - $3.07 Million
-40,329 Reduced 4.52%
851,321 $64.9 Million
Q1 2024

May 15, 2024

BUY
$67.36 - $77.59 $22.2 Million - $25.5 Million
329,097 Added 58.5%
891,650 $65.4 Million
Q4 2023

Feb 14, 2024

BUY
$64.27 - $69.9 $1.15 Million - $1.25 Million
17,837 Added 3.27%
562,553 $39.1 Million
Q2 2023

Aug 14, 2023

BUY
$53.34 - $63.11 $1.6 Million - $1.89 Million
29,920 Added 5.81%
544,716 $34.4 Million
Q1 2023

May 12, 2023

BUY
$51.63 - $56.93 $24.2 Million - $26.7 Million
468,685 Added 1016.43%
514,796 $29.3 Million
Q4 2022

Feb 10, 2023

BUY
$51.15 - $57.45 $92,274 - $103,639
1,804 Added 4.07%
46,111 $2.39 Million
Q3 2022

Nov 14, 2022

SELL
$49.9 - $57.32 $3,592 - $4,127
-72 Reduced 0.16%
44,307 $2.32 Million
Q2 2022

Aug 12, 2022

BUY
$49.62 - $58.13 $47,387 - $55,514
955 Added 2.2%
44,379 $2.46 Million
Q1 2022

May 16, 2022

SELL
$48.27 - $65.25 $7.91 Million - $10.7 Million
-163,832 Reduced 79.05%
43,424 $2.42 Million
Q4 2021

Feb 08, 2022

SELL
$59.5 - $67.25 $5.92 Million - $6.69 Million
-99,416 Reduced 32.42%
207,256 $13.6 Million
Q3 2021

Nov 15, 2021

SELL
$60.19 - $75.29 $6.35 Million - $7.94 Million
-105,506 Reduced 25.6%
306,672 $20 Million
Q2 2021

Sep 13, 2021

BUY
$62.12 - $74.2 $25.6 Million - $30.6 Million
412,178 New
412,178 $30.3 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $13.2B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.